This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Bile Acid Synthesis Defect
and you are
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The primary purpose of the study is to evaluate the therapeutic efficacy and safety of cholic acid in subjects with identified inborn errors of bile acid synthesis.

Provided treatments

  • Drug: Cholic Acid

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01438411. The sponsor of the trial is Retrophin, Inc. and it is looking for 53 volunteers for the current phase.
Official trial title:
An Open Label, Single Center, Nonrandomized Continuation Study of Cholic Acid Capsules to Treat Subjects With Inborn Errors of Bile Acid Synthesis